Akela Pharma Inc. AKLPF

Healthcare Biotechnology

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."

GREY:AKLPF - Post by User

Akela Pharma Inc.

<< Previous

Bullboard Posts

Next >>

Post by Biostocks01on Apr 11, 2012 11:33am

329 Views

Post# 19780538

Emmelot, Rudy - CEO

He still buys...

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Unit Price
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.153 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.153 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.148 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.133 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	3,000	.143 USD
Sign up for an account or login above to see all SEDI filings within the past 6 months.